Report cover image

Global Rare Hemophilia Factors Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18749932

Description

Global Rare Hemophilia Factors Databank Market Report


The Rare Hemophilia Factors market was valued at $2,281.6 Million in 2020, and is projected to reach $3,649.3 Million by 2029 growing at a CAGR of 5.41% from 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. Factor I segment is anticipated to reach $957.5 Million by 2029 with the highest CAGR of 5.51%. Factor II and Factor I segments collectively expected to account for about 75.3% share of the Rare Hemophilia Factors market in 2020, with the former constituting around 49.3% share. Factor I and Factor II segments are expected to witness significant growth rates at a CAGR of 5.51% and 5.44% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 75.3% in the overall Rare Hemophilia Factors market in 2020, and is anticipated to reach 75.6% by 2029.

Table of Contents

100 Pages
1. Global Rare Hemophilia Factors Market, By Application
1.1. Overview
1.2. Factor II
1.2.1 Factor II Market, By Region
1.2.1.1 North America Factor II Market, By Country
1.2.1.2 Europe Factor II Market, By Country
1.2.1.3 Asia-Pacific Factor II Market, By Country
1.2.1.4 Rest of World Factor II Market, By Country
1.3. Factor I
1.3.1 Factor I Market, By Region
1.3.1.1 North America Factor I Market, By Country
1.3.1.2 Europe Factor I Market, By Country
1.3.1.3 Asia-Pacific Factor I Market, By Country
1.3.1.4 Rest of World Factor I Market, By Country
1.4. Factor V
1.4.1 Factor V Market, By Region
1.4.1.1 North America Factor V Market, By Country
1.4.1.2 Europe Factor V Market, By Country
1.4.1.3 Asia-Pacific Factor V Market, By Country
1.4.1.4 Rest of World Factor V Market, By Country
2. Global Rare Hemophilia Factors Market, By Product
2.1. Overview
2.2. Factor Concentrates
2.2.1 Factor Concentrates Market, By Region
2.2.1.1 North America Factor Concentrates Market, By Country
2.2.1.2 Europe Factor Concentrates Market, By Country
2.2.1.3 Asia-Pacific Factor Concentrates Market, By Country
2.2.1.4 Rest of World Factor Concentrates Market, By Country
2.3. Cryoprecipitate
2.3.1 Cryoprecipitate Market, By Region
2.3.1.1 North America Cryoprecipitate Market, By Country
2.3.1.2 Europe Cryoprecipitate Market, By Country
2.3.1.3 Asia-Pacific Cryoprecipitate Market, By Country
2.3.1.4 Rest of World Cryoprecipitate Market, By Country
2.4. Fresh Frozen Plasma
2.4.1 Fresh Frozen Plasma Market, By Region
2.4.1.1 North America Fresh Frozen Plasma Market, By Country
2.4.1.2 Europe Fresh Frozen Plasma Market, By Country
2.4.1.3 Asia-Pacific Fresh Frozen Plasma Market, By Country
2.4.1.4 Rest of World Fresh Frozen Plasma Market, By Country
3. Global Rare Hemophilia Factors Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Rare Hemophilia Factors Market, By Application
3.2.2 North America Rare Hemophilia Factors Market, By Product
3.2.3 North America Rare Hemophilia Factors Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Rare Hemophilia Factors Market, By Application
3.2.3.1.2 U.S. Rare Hemophilia Factors Market, By Product
3.2.3.2 Canada
3.2.3.2.1 Canada Rare Hemophilia Factors Market, By Application
3.2.3.2.2 Canada Rare Hemophilia Factors Market, By Product
3.2.3.3 Mexico
3.2.3.3.1 Mexico Rare Hemophilia Factors Market, By Application
3.2.3.3.2 Mexico Rare Hemophilia Factors Market, By Product
3.3. Europe
3.3.1 Europe Rare Hemophilia Factors Market, By Application
3.3.2 Europe Rare Hemophilia Factors Market, By Product
3.3.3 Europe Rare Hemophilia Factors Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Rare Hemophilia Factors Market, By Application
3.3.3.1.2 Germany Rare Hemophilia Factors Market, By Product
3.3.3.2 France
3.3.3.2.1 France Rare Hemophilia Factors Market, By Application
3.3.3.2.2 France Rare Hemophilia Factors Market, By Product
3.3.3.3 UK
3.3.3.3.1 UK Rare Hemophilia Factors Market, By Application
3.3.3.3.2 UK Rare Hemophilia Factors Market, By Product
3.3.3.4 Italy
3.3.3.4.1 Italy Rare Hemophilia Factors Market, By Application
3.3.3.4.2 Italy Rare Hemophilia Factors Market, By Product
3.3.3.5 Spain
3.3.3.5.1 Spain Rare Hemophilia Factors Market, By Application
3.3.3.5.2 Spain Rare Hemophilia Factors Market, By Product
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Rare Hemophilia Factors Market, By Application
3.3.3.6.2 Rest of Europe Rare Hemophilia Factors Market, By Product
3.4. Asia-Pacific
3.4.1 Asia-Pacific Rare Hemophilia Factors Market, By Application
3.4.2 Asia-Pacific Rare Hemophilia Factors Market, By Product
3.4.3 Asia-Pacific Rare Hemophilia Factors Market, By Country
3.4.3.1 China
3.4.3.1.1 China Rare Hemophilia Factors Market, By Application
3.4.3.1.2 China Rare Hemophilia Factors Market, By Product
3.4.3.2 India
3.4.3.2.1 India Rare Hemophilia Factors Market, By Application
3.4.3.2.2 India Rare Hemophilia Factors Market, By Product
3.4.3.3 Japan
3.4.3.3.1 Japan Rare Hemophilia Factors Market, By Application
3.4.3.3.2 Japan Rare Hemophilia Factors Market, By Product
3.4.3.4 Australia
3.4.3.4.1 Australia Rare Hemophilia Factors Market, By Application
3.4.3.4.2 Australia Rare Hemophilia Factors Market, By Product
3.4.3.5 South Korea
3.4.3.5.1 South Korea Rare Hemophilia Factors Market, By Application
3.4.3.5.2 South Korea Rare Hemophilia Factors Market, By Product
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Rare Hemophilia Factors Market, By Application
3.4.3.6.2 Rest of Asia Rare Hemophilia Factors Market, By Product
3.5. Rest of World
3.5.1 Rest of World Rare Hemophilia Factors Market, By Application
3.5.2 Rest of World Rare Hemophilia Factors Market, By Product
3.5.3 Rest of World Rare Hemophilia Factors Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Rare Hemophilia Factors Market, By Application
3.5.3.1.2 Brazil Rare Hemophilia Factors Market, By Product
3.5.3.2 South Africa
3.5.3.2.1 South Africa Rare Hemophilia Factors Market, By Application
3.5.3.2.2 South Africa Rare Hemophilia Factors Market, By Product
3.5.3.3 GCC
3.5.3.3.1 GCC Rare Hemophilia Factors Market, By Application
3.5.3.3.2 GCC Rare Hemophilia Factors Market, By Product
3.5.3.4 RoW Countries
3.5.3.4.1 RoW Countries Rare Hemophilia Factors Market, By Application
3.5.3.4.2 RoW Countries Rare Hemophilia Factors Market, By Product
RoW Countries Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 2. Factor II Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Factor II Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Factor II Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Factor II Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Factor II Market Value, By Country, 2020-2029, Million USD
TABLE 7. Factor I Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America Factor I Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe Factor I Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific Factor I Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World Factor I Market Value, By Country, 2020-2029, Million USD
TABLE 12. Factor V Market Value, By Region, 2020-2029, Million USD
TABLE 13. North America Factor V Market Value, By Country, 2020-2029, Million USD
TABLE 14. Europe Factor V Market Value, By Country, 2020-2029, Million USD
TABLE 15. Asia-Pacific Factor V Market Value, By Country, 2020-2029, Million USD
TABLE 16. Rest of World Factor V Market Value, By Country, 2020-2029, Million USD
TABLE 17. Global Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 18. Factor Concentrates Market Value, By Region, 2020-2029, Million USD
TABLE 19. North America Factor Concentrates Market Value, By Country, 2020-2029, Million USD
TABLE 20. Europe Factor Concentrates Market Value, By Country, 2020-2029, Million USD
TABLE 21. Asia-Pacific Factor Concentrates Market Value, By Country, 2020-2029, Million USD
TABLE 22. Rest of World Factor Concentrates Market Value, By Country, 2020-2029, Million USD
TABLE 23. Cryoprecipitate Market Value, By Region, 2020-2029, Million USD
TABLE 24. North America Cryoprecipitate Market Value, By Country, 2020-2029, Million USD
TABLE 25. Europe Cryoprecipitate Market Value, By Country, 2020-2029, Million USD
TABLE 26. Asia-Pacific Cryoprecipitate Market Value, By Country, 2020-2029, Million USD
TABLE 27. Rest of World Cryoprecipitate Market Value, By Country, 2020-2029, Million USD
TABLE 28. Fresh Frozen Plasma Market Value, By Region, 2020-2029, Million USD
TABLE 29. North America Fresh Frozen Plasma Market Value, By Country, 2020-2029, Million USD
TABLE 30. Europe Fresh Frozen Plasma Market Value, By Country, 2020-2029, Million USD
TABLE 31. Asia-Pacific Fresh Frozen Plasma Market Value, By Country, 2020-2029, Million USD
TABLE 32. Rest of World Fresh Frozen Plasma Market Value, By Country, 2020-2029, Million USD
TABLE 33. Global Rare Hemophilia Factors Market Value, By Region, 2020-2029, Million USD
TABLE 34. North America Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 35. North America Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 36. North America Rare Hemophilia Factors Market Value, By Country, 2020-2029, Million USD
TABLE 37. U.S. Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 38. U.S. Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 39. Canada Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 40. Canada Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 41. Mexico Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 42. Mexico Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 43. Europe Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 44. Europe Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 45. Europe Rare Hemophilia Factors Market Value, By Country, 2020-2029, Million USD
TABLE 46. Germany Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 47. Germany Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 48. France Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 49. France Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 50. UK Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 51. UK Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 52. Italy Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 53. Italy Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 54. Spain Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 55. Spain Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 56. Rest of Europe Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 57. Rest of Europe Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 58. Asia-Pacific Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 59. Asia-Pacific Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 60. Asia-Pacific Rare Hemophilia Factors Market Value, By Country, 2020-2029, Million USD
TABLE 61. China Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 62. China Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 63. India Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 64. India Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 65. Japan Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 66. Japan Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 67. Australia Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 68. Australia Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 69. South Korea Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 70. South Korea Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 71. Rest of Asia Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 72. Rest of Asia Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 73. Rest of World Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 74. Rest of World Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 75. Rest of World Rare Hemophilia Factors Market Value, By Country, 2020-2029, Million USD
TABLE 76. Brazil Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 77. Brazil Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 78. South Africa Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 79. South Africa Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 80. GCC Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 81. GCC Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
TABLE 82. RoW Countries Rare Hemophilia Factors Market Value, By Application, 2020-2029, Million USD
TABLE 83. RoW Countries Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD
RoW Countries Rare Hemophilia Factors Market Value, By Product, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us